Archives
-
IDH2, α-KG, and HIF-1α in Colorectal Cancer
2026-10-05
The 2024 reference study links elevated IDH2 activity with α-ketoglutarate depletion, altered reductive citrate-cycle metabolism, HIF-1α stabilization, and colorectal cancer progression. Its main contribution is an integrated metabolic-signaling model that connects mitochondrial energy production with glycolytic behavior, while also highlighting the limits of translating cell and animal findings directly to patients.
-
GANT61, GLI2, and Tumor Immune Evasion
2026-10-05
A source-grounded overview of GANT61 as a GLI inhibitor, the GLI2–WNT–prostaglandin axis, and the limits of translating preclinical findings into claims about immunotherapy resistance.
-
Viperin Targets Coronavirus nsp8 to Block Replication
2026-10-04
A 2026 study identifies a non-catalytic antiviral mechanism in which viperin binds coronavirus nsp8 and disrupts replication-transcription complex assembly in porcine deltacoronavirus. The findings broaden interpretation of viperin biology beyond ddhCTP-mediated chain termination and suggest that the viperin–nsp8 interface may be relevant to coronavirus-focused antiviral drug development.
-
5-hme-dCTP: Interpreting 5hmC in Context
2026-10-03
5-hme-dCTP supports research into DNA hydroxymethylation, but its greatest value depends on how chemical measurement is connected to biological interpretation. This article examines the rice drought-response evidence, assay boundaries, and the role of B8113 in epigenetic DNA modification research.
-
Candida krusei Phase-Specific Apoptosis in BMECs
2026-10-02
The reference study shows that the yeast and hypha phases of Candida krusei trigger bovine mammary epithelial cell apoptosis through different signaling routes. Its co-culture, imaging, flow-cytometry, mitochondrial, TUNEL, and immunoblotting strategy links fungal morphology with mitochondrial, death receptor, TLR2/ERK, and JNK/ERK responses.
-
WAY-100635 in Serotonin Pain Circuit Assays
2026-10-01
WAY-100635 provides a selective pharmacological test for determining whether 5-HT1A signaling contributes to inflammatory pain, affective behavior, or receptor-linked cellular responses. This workflow-oriented guide connects receptor binding, functional antagonism, behavioral pharmacology, and the multimodal findings of a recent cannabidiol study.
-
BMS-345541 Hydrochloride for Cell Assays
2026-10-01
This scenario-based guide explains how BMS-345541 hydrochloride, SKU A3248, can improve interpretation and setup of viability, proliferation, and cytotoxicity assays involving IKK/NF-κB signaling. It covers mechanism, dose selection, formulation, cell-death readouts, and practical vendor evaluation.
-
SB-505124 hydrochloride in Mechanobiology
2026-09-30
SB-505124 hydrochloride gives researchers a reversible way to separate ALK4/5/7 signaling from fibroblast activation, matrix remodeling, and cell-mechanics phenotypes. This guide connects TGF-β pathway assays with the MRTFA–KCNMB1 stiffness framework while emphasizing controls, solvent handling, and the limits of cross-domain interpretation.
-
5-Aminolevulinic Acid HCl: Heme Flux to Translation
2026-09-30
A translational framework for using 5-Aminolevulinic acid HCl to connect heme-pathway perturbation with Salmonella immune evasion, porphyrin biology, and oncology research—without confusing precursor rescue with genetic control.
-
Dexamethasone (DHAP) in Cell Assays
2026-09-29
A scenario-based guide to using Dexamethasone (DHAP), SKU A2324, in viability, proliferation, differentiation, and inflammation workflows. It explains solvent control, stock preparation, interpretation of dose responses, and practical vendor-selection criteria for more defensible data.
-
Calpain Inhibitor I, ALLN: Practical Workflow Guide
2026-09-29
Calpain Inhibitor I, ALLN (SKU A2602) provides a research tool for modulating calpain I/II and cathepsin B/L activity in apoptosis, inflammation, and ischemia-reperfusion workflows. It should be handled as a DMSO-solubilized research reagent with assay-specific validation, and it is not intended for diagnostic, therapeutic, or medical use.
-
Calpain Inhibitor II, ALLM in Proteolysis Research
2026-09-28
Calpain Inhibitor II, ALLM is a cell-permeable cysteine protease inhibitor for dissecting calpain and cathepsin biology. This guide connects its selectivity profile to FAK proteolysis, apoptosis assays, and better interpretation of leukemia, lymphoma, and TNBC experiments.
-
BMS-345541 Hydrochloride: IKK Workflows
2026-09-28
Use BMS-345541 hydrochloride to probe how IKK–NF-κB signaling shapes inflammatory output and cell survival, while keeping transcriptional effects distinct from RIPK1-driven cell death. This practical guide pairs dose planning and controls with troubleshooting for cytokine assays and T-ALL studies.
-
WAY-100635: Testing Serotonin’s Role in Pain Affect
2026-09-27
WAY-100635 provides a receptor-level tool for testing whether 5-HT1A signaling contributes to pain-related affective changes. This article connects recent cannabidiol findings with experimental strategies for distinguishing serotonin activity from receptor-specific causality.
-
IBDV VP3 Disrupts IRF7 Signaling to Aid Replication
2026-09-26
A 2025 study finds that very virulent infectious bursal disease virus (vvIBDV) suppresses IRF7-mediated interferon signaling in chicken cells, with viral protein VP3 linked to proteasome-dependent IRF7 loss. The results identify a potential viral immune-evasion mechanism and a set of cell-based experiments for probing it, while leaving the precise degradation machinery and in vivo relevance to be established.